RxDoctor Payments Data

Cynthia Thomas, DO

Family Medicine · Apple Valley, CANPI 1083767636

Payments from drug & device makers

$443in general payments, 2019–2025

Across 22 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$177
  • GSK$55
  • Vertex$39
  • Amgen$39
  • Boehringer Ingelheim$25
  • AMAG Pharmaceuticals, Inc.$20
  • plus $88 from 5 others

What the payments were for

  • Food & beverage$40391%
  • Education$409%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$443 in reported general payments places this provider in the 60th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$248,500
Medicare patients
258
Services billed
3,253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$39,374
JardianceEmpagliflozin13$22,465
EliquisApixaban26$18,960
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,598
MyrbetriqMirabegron17$10,383
Breo ElliptaFluticasone/Vilanterol23$9,856
OxycontinOxycodone Hcl12$6,147
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$5,853
Estradiol68$4,017
SynthroidLevothyroxine Sodium56$3,951
Levothyroxine Sodium244$3,834
YuvafemEstradiol21$2,587
SymbicortBudesonide/Formoterol Fumarate11$2,209
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$2,186
Liothyronine Sodium35$1,676

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$39,37435 claims
Boehringer IngelheimJardiance$25$22,46513 claims
GSKTrelegy Ellipta, Breo Ellipta$55$20,45435 claims
AbbVieSynthroid, Armour Thyroid$18$5,28077 claims
AstraZenecaSymbicort$19$2,20911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 10,533 family medicine providers in California.

Other family medicine in Apple Valley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →